Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin
View/ Open
Author
Pham, Tan
Wen, Jennifer R.
Mlynarchik, Andrew K.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/s41598-018-27416-yMetadata
Show full item recordCitation
Hagita, Sumihiko, Maximillian A. Rogers, Tan Pham, Jennifer R. Wen, Andrew K. Mlynarchik, Masanori Aikawa, and Elena Aikawa. 2018. “Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin.” Scientific Reports 8 (1): 9006. doi:10.1038/s41598-018-27416-y. http://dx.doi.org/10.1038/s41598-018-27416-y.Abstract
The sorting receptor Sortilin functions in the regulation of glucose and lipid metabolism. Dysfunctional lipid uptake, storage, and metabolism contribute to several major human diseases including atherosclerosis and obesity. Sortilin associates with cardiovascular disease; however, the role of Sortilin in adipose tissue and lipid metabolism remains unclear. Here we show that in the low-density lipoprotein receptor-deficient (Ldlr−/−) atherosclerosis model, Sortilin deficiency (Sort1−/−) in female mice suppresses Niemann-Pick type C1-Like 1 (Npc1l1) mRNA levels, reduces body and white adipose tissue weight, and improves brown adipose tissue function partially via transcriptional downregulation of Krüppel-like factor 4 and Liver X receptor. Female Ldlr−/−Sort1−/− mice on a high-fat/cholesterol diet had elevated plasma Fibroblast growth factor 21 and Adiponectin, an adipokine that when reduced is associated with obesity and cardiovascular disease-related factors. Additionally, Sort1 deficiency suppressed cholesterol absorption in both female mice ex vivo intestinal tissue and human colon Caco-2 cells in a similar manner to treatment with the NPC1L1 inhibitor ezetimibe. Together our findings support a novel role of Sortilin in energy regulation and lipid homeostasis in female mice, which may be a potential therapeutic target for obesity and cardiovascular disease.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998044/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:37298428
Collections
- HMS Scholarly Articles [17918]
Contact administrator regarding this item (to report mistakes or request changes)